🇺🇸 FDA
Patent

US 9642843

Pharmaceutical compounds and use of same in cancer and tauopathies

granted A61KA61K31/395A61K31/428

Quick answer

US patent 9642843 (Pharmaceutical compounds and use of same in cancer and tauopathies) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/395, A61K31/428, A61K31/4439, A61K38/05